Literature DB >> 7576323

Micronutrient levels in HIV-1-infected children.

B A Periquet1, N M Jammes, W E Lambert, J Tricoire, M M Moussa, J Garcia, J Ghisolfi, J Thouvenot.   

Abstract

OBJECTIVE: Micronutrients (zinc, copper, selenium, vitamin A, E, and carotenoids) are essential for the integrity of host defences. This study was designed to determine the prevalence of abnormalities of the micronutrient levels in HIV-1-seropositive children.
DESIGN: Prospective study.
SETTING: The study was performed on HIV-1-infected children at the Paediatric Haematology and Oncology Unit of Toulouse Hospital, France. PATIENTS: Twenty-one children, suffering from HIV-1 infection and 21 control subjects of similar age (2-9 years) were included in the study. In the HIV-1-infected children, two subgroups were considered according to stage (non-AIDS or AIDS), based on the Centers for Disease Control and Prevention 1987 criteria.
RESULTS: The first statistically significant deficiencies occurred at non-AIDS stage and were confirmed at AIDS stage: P < 0.05 for lycopene, retinol, tocopherol and P < 0.001 for transthyretin and serum albumin. Levels of copper (40%) and long-chain polyunsaturated fatty acids (21%) were higher in the non-AIDS group than the controls.
CONCLUSION: Biological impairing of the micronutrient levels was observed in the non-AIDS stage without clinical sign. This information is useful in delineating eventual and well considered nutritional intervention strategies that may improve the clinical status of HIV-1-infected children and perhaps alter the course of their disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576323     DOI: 10.1097/00002030-199508000-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  Role of selenium in HIV infection.

Authors:  Cosby A Stone; Kosuke Kawai; Roland Kupka; Wafaie W Fawzi
Journal:  Nutr Rev       Date:  2010-11       Impact factor: 7.110

3.  Stunting and wasting are associated with poorer psychomotor and mental development in HIV-exposed Tanzanian infants.

Authors:  Christine M McDonald; Karim P Manji; Roland Kupka; David C Bellinger; Donna Spiegelman; Rodrick Kisenge; Gernard Msamanga; Wafaie W Fawzi; Christopher P Duggan
Journal:  J Nutr       Date:  2012-12-19       Impact factor: 4.798

4.  Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication.

Authors:  J W Maciaszek; S J Coniglio; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Antioxidants in HIV positive children.

Authors:  Aruna Srinivas; Bina F Dias
Journal:  Indian J Pediatr       Date:  2008-05-18       Impact factor: 1.967

6.  Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages.

Authors:  Timothy M Hanley; Heather L B Kiefer; Aletta C Schnitzler; Jennifer E Marcello; Gregory A Viglianti
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin E.

Authors:  Jacqueline P Monteiro; Laura Freimanis-Hance; Lidiane B Faria; Marisa M Mussi-Pinhata; James Korelitz; Hélio Vannucchi; Wladimir Queiroz; Regina C M Succi; Rohan Hazra
Journal:  Nutr Res       Date:  2009-10       Impact factor: 3.315

8.  Predictors of stunting, wasting and underweight among Tanzanian children born to HIV-infected women.

Authors:  C M McDonald; R Kupka; K P Manji; J Okuma; R J Bosch; S Aboud; R Kisenge; D Spiegelman; W W Fawzi; C P Duggan
Journal:  Eur J Clin Nutr       Date:  2012-10-03       Impact factor: 4.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.